InExoplat Co.
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $2.3M
Investors
- 1
About InExoplat Co.
, operates as a biopharmaceutical company that develops exosome-based drugs that are being used in the procedure of stem cell therapies. Inexoplat offers science and drug development solutions that include developing anticancer agents that expand their application to solid tumors. The company utilizes exosomes, extracellular vesicles secreted by cells, for drug delivery of anticancer drugs. This technology aims to protect drugs, ensure stability, and enhance.
Who invested in InExoplat Co.
1 investor across 1 round
See all investors in InExoplat Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 7, 2023
Amount
$2.3M
Investors
Questions about InExoplat Co.
Who invested in InExoplat Co.?
InExoplat Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InExoplat Co. raised?
InExoplat Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did InExoplat Co. last raise money?
InExoplat Co.'s most recent round on record is a Series A, in Dec 2023.
What does InExoplat Co. do?
, operates as a biopharmaceutical company that develops exosome-based drugs that are being used in the procedure of stem cell therapies.
Where is InExoplat Co. headquartered?
InExoplat Co. is headquartered in Pohang, South Korea.
Which VCs invest in companies like InExoplat Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at InExoplat Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like InExoplat Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.